2.5.11. Section 11: Technology Readiness.

2.5.11.1. The purpose of this section is to highlight known technological challenges which may impact the ability to reach the level of performance identified in the performance attributes (KPPs, KSAs, or APAs), or represent risk to delivering capabilities on schedule and within budget. This information from the Technology Readiness Assessment (TRA) may be used to inform lifecycle cost, performance, schedule, and quantity tradeoff discussions during review and validation of the CDD.

2.5.11.1.1. For the CDD generated prior to the Milestone B acquisition decision, this section identifies technological risk areas that require attention during the EMD phase of acquisition.

2.5.11.1.2. In cases where the CDD describes multiple increments of a capability solution, this section must describe the critical technologies to be matured for each increment. This may also be addressed in the incremental annex as they are developed for a capability solution.

2.5.11.2. For each Critical Technology Element (CTE) with a Technology Readiness Level (TRL) of less than TRL-6, discuss potential workarounds to achieve partial or complete program success in the event that the technology does not mature as anticipated. Additionally, highlight how incremental acquisition strategies and/or MOSA is being used to enable flexibility in critical technology areas. Where known, include decision points and criteria for implementing the potential workaround(s).

2.5.11.3. Sponsors shall address Exportability "Allied/Partner Interoperability and Coalition Use" as per the Conventional Arms Transfer Policy. Sponsors must consider existing export controls, controlled technical information assessments, and the identification of critical program information when addressing exportability. Coordination with the Defense Technology Security Administration and the sponsor’s associated Military Department Counterintelligence Organization can assist for scoping requirements in the Intelligence Supportability Section.